Yating Zheng

发表

Metastatic Colorectal Cancer Patient With Microsatellite Stability and BRAFV600E Mutation Showed a Complete Metabolic Response to PD-1 Blockade and Bevacizumab: A Case Report

Meng Li, Zhiwei Xiao, Chongkai Fang, 2021, Frontiers in Oncology.

Neoadjuvant programmed death-1 blockade plus chemotherapy in locally advanced esophageal squamous cell carcinoma

Jian-Hua Fu, Qian-wen Liu, Yihuai Hu, 2021, Annals of translational medicine.

Investigation of PALB2 Mutation and Correlation With Immunotherapy Biomarker in Chinese Non-Small Cell Lung Cancer Patients

Jiexia Zhang, Xiangyang Cheng, Xue Hu, 2022, Frontiers in Oncology.

Combined analysis of T cell activation and T cell-mediated cytotoxicity by imaging cytometry

A. Courtney, Yating Zheng, Monica K. Chanda, 2022, Journal of immunological methods.

Homologous recombination repair gene mutations as a predictive biomarker for immunotherapy in patients with advanced melanoma

C. You, Chengzhi Zhou, Y. Pan, 2022, Frontiers in Immunology.

Case report: Primary hepatocellular carcinoma with portal vein tumor thrombus characterized by active tumor immune microenvironment achieving a complete response following treatment of combined immunotherapy

Tingting Chen, Guo-lin He, L. Cai, 2022, Frontiers in Immunology.

KEAP1/NFE2L2 Mutations of Liquid Biopsy as Prognostic Biomarkers in Patients With Advanced Non-Small Cell Lung Cancer: Results From Two Multicenter, Randomized Clinical Trials

Lawrence W. C. Chan, Haiyu Zhou, G. Qiao, 2021, Frontiers in Oncology.

Comprehensive analysis of DNA damage repair deficiency in 10,284 pan-cancer study

Chunli Wang, Yanni Xiao, Zhongjun Li, 2021, Annals of translational medicine.

Case report: an initially unresectable stage III pulmonary sarcomatoid carcinoma qith EGFR mutation achieving pathological complete response following neoadjuvant therapy with osimertinib plus chemotherapy

Xiguang Liu, S. Mai, Yating Zheng, 2022, Frontiers in Oncology.

Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial

Xu Zhang, Haoqiang He, Ting Bei, 2023, Journal of Translational Medicine.

A Refractory Case of CDKN2A/B Loss Metastatic Intrahepatic Cholangiocarcinoma Achieving a Partial Response After First-Line Treatment with Palbociclib

Chuan-Chao Wang, Tingting Chen, Yating Zheng, 2023, OncoTargets and therapy.

An unresectable and metastatic intrahepatic cholangiocarcinoma with EML4-ALK rearrangement achieving partial response after first-line treatment with ensartinib: a case report

Ying Tian, Yating Zheng, Mengli Huang, 2023, Frontiers in oncology.